Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review

Chloroquine and Hydroxychloroquine for the Prevention and Treatment of COVID-19: A Fiction, Hope or Hype? An Updated Review

Sultan AM Saghir,1 Naif A AlGabri,2,3 Mahmoud M Alagawany,4 Youssef A Attia,5,6 Salem R Alyileili,7 Shaaban S Elnesr,8 Manal E Shafi,9 Omar YA Al-shargi,10 Nader Al-balagi,11 Abdullah S Alwajeeh,12 Omar SA Alsalahi,13 Amlan K Patra,14 Asmaa F Khafaga,15 Ahmed Negida,16,17 Ahmed Noreldin,18 Wesam Al-...

Full description

Bibliographic Details
Main Authors:	Saghir SAM, AlGabri NA, Alagawany MM, Attia YA, Alyileili SR, Elnesr SS, Shafi ME, Al-shargi OYA, Al-balagi N, Alwajeeh AS, Alsalahi OS, Patra AK, Khafaga AF, Negida A, Noreldin A, Al-Amarat W, Almaiman AA, El-Tarabily KA, Abd El-Hack ME
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-04-01
Series:	Therapeutics and Clinical Risk Management
Subjects:	antiviral drugs chloroquine covid-19 drug safety hydroxychloroquine sars-cov-2 treatments
Online Access:	https://www.dovepress.com/chloroquine-and-hydroxychloroquine-for-the-prevention-and-treatment-of-peer-reviewed-fulltext-article-TCRM

Similar Items

Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review
by: Al-Gabri NA, et al.
Published: (2021-07-01)

Prevalence and Association of Transfusion Transmitted Infections with ABO and Rh Blood Groups among Blood Donors at the National Blood Bank, Amman, Jordan
by: Amir M. Al Hroob, et al.
Published: (2020-12-01)

Combination therapy for malaria in Africa: hype or hope?
by: Bloland Peter B., et al.
Published: (2000-01-01)

Nanotechnology and cancer therapeutics: delivering on the hype?
by: Louis Gautier
Published: (2023-02-01)

Hydroxychloroquine in COVID-19 Patients: Pros and Cons
by: Nour K. Younis, et al.
Published: (2020-11-01)

Combination therapy for malaria in Africa: hype or hope?
by: Peter B. Bloland, et al.

Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug Transporters
by: Johanna Weiss, et al.
Published: (2020-09-01)

κ-Carrageenan/Sodium Alginate: A New Synthesis Route and Rapid Adsorbent for Hydroxychloroquine Drug
by: Mohammed Kassim Al-Hussainawy, et al.
Published: (2023-02-01)

Implications of the use of hydroxychloroquine on cardioactive drugs
by: Soumitra Ghosh, et al.
Published: (2021-01-01)

2‐Deoxyglucose and hydroxychloroquine HPLC‐MS–MS analytical methods and pharmacokinetic interactions after oral co‐administration in male rats
by: Dongxiao Sun, et al.
Published: (2024-02-01)

Hyperpigmentation Induced by Hydroxychloroquine: A Case Report
by: Bhanukumar Muthaiah, et al.
Published: (2019-07-01)

Mechanisms and the clinical relevance of complex drug–drug interactions
by: Roberts AG, et al.
Published: (2018-09-01)

Hydroxychloroquine‐induced erythema multiforme
by: Dimitra Koumaki, et al.
Published: (2020-03-01)

Chloroquine or Hydroxychloroquine for COVID‐19: Is Cardiotoxicity a Concern?
by: Timothy J. Kamp, et al.
Published: (2020-06-01)

Drug-coated balloon in the treatment of coronary bifurcation lesions: A hope or hype?
by: Debabrata Dash, et al.
Published: (2022-11-01)

Case Report: Scleral hyperpigmentation associated with oral hydroxychloroquine use
by: Caroline Maretz, et al.
Published: (2023-06-01)

Does administration of hydroxychloroquine/amiodarone affect the efficacy of enzyme replacement therapy for Fabry mice?
by: Takahiro Tsukimura, et al.
Published: (2024-06-01)

Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?
by: Chen Fu, et al.
Published: (2023-02-01)

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients
by: Miao Zhang, et al.
Published: (2021-02-01)

Evaluation of controlled hydroxychloroquine releasing performance from calcium-alginate beads
by: Canan Armutcu, et al.
Published: (2021-09-01)

Severe COVID-19 Infection While on Long Standing Therapy with Hydroxychloroquine
by: Kartik Ramakrishna, et al.
Published: (2020-06-01)

Patterns of Drug Utilization and Self-Medication Practices: A Cross Sectional Study
by: Hamod Al-Omrani, et al.
Published: (2023-11-01)

Ototoxic and Vestibulotoxic Effects of Chloroquine/Hydroxychloroquine and Remdesivir in the Treatment of COVID-19: Update Review
by: Vida Rahimi, et al.
Published: (2023-07-01)

The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institutionle
by: Rebecca S. Overbury, et al.
Published: (2021-09-01)

"Visual Identity as a system to enhance the City Image “an analytical study of mega events”"
by: Ahmed Helmy, et al.
Published: (2019-05-01)

Adverse drug reaction profile of prophylactic hydroxychloroquine for COVID-19 among doctors
by: Rajesh K Kulkarni, et al.
Published: (2020-01-01)

Ontology-Based Classification and Analysis of Adverse Events Associated With the Usage of Chloroquine and Hydroxychloroquine
by: Jamie Ngai, et al.
Published: (2022-03-01)

Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia
by: Emmaline Zantua Fernando, et al.
Published: (2021-01-01)

Sustaining Life versus Altering Life-Saving Drugs: Insights to Explain the Paradoxical Effect of Extracorporeal Membrane Oxygenation on Drugs
by: Emna Abidi, et al.
Published: (2023-05-01)

Household Drug Stockpiling and Panic Buying of Drugs During the COVID-19 Pandemic: A Study From Jordan
by: Sura Al Zoubi, et al.
Published: (2021-12-01)

Polypharmacy and potential drug–drug interactions in patients with rheumatoid arthritis
by: Zakaria M Al-Ghazaly, et al.
Published: (2022-01-01)

Hydroxychloroquine Toxicity in the Vital Organs of the Body: In Vivo Study
by: Meshref Alruwaili, et al.
Published: (2023-07-01)

Sweet’s Syndrome Following Therapy with Hydroxychloroquine in a Patient Affected with Elderly-Onset Primary Sjogren’s Syndrome
by: Ciro Manzo, et al.
Published: (2019-11-01)

Iron Oxide Mesoporous Magnetic Nanostructures with High Surface Area for Enhanced and Selective Drug Delivery to Metastatic Cancer Cells
by: Kheireddine El-Boubbou, et al.
Published: (2021-04-01)

The effects of state rules on opioid prescribing in Indiana
by: Morhaf Al Achkar, et al.
Published: (2018-01-01)

Pharmacists’ knowledge, familiarity, and attitudes towards biosimilar drugs among practicing Jordanian pharmacists: A cross sectional study
by: Osama H. Abusara, et al.
Published: (2023-08-01)

A Capillary Electrophoresis-Based Method for the Measurement of Hydroxychloroquine and Its Active Metabolite Desethyl Hydroxychloroquine in Whole Blood in Patients with Rheumatoid Arthritis
by: Salvatore Sotgia, et al.
Published: (2022-06-01)

Drug utilisation in adult, paediatric and neonatal intensive care units, with an emphasis on systemic antimicrobials
by: Kannan Sridharan, et al.
Published: (2021-02-01)

Hydroxychloroquine Enhances Cytotoxic Properties of Extracellular Vesicles and Extracellular Vesicle–Mimetic Nanovesicles Loaded with Chemotherapeutics
by: Sergey Brezgin, et al.
Published: (2023-02-01)

Mechanic's Hands and Drug Eruption to Hydroxychloroquine: Precious Diagnostic Tools
by: Maria Mendonça Sanches, et al.
Published: (2020-07-01)